• Contact
Augurex
  • Solutions
    • Solution Portfolio
    • Rheumatoid Arthritis
    • Axial Spondyloarthritis
    • Find a Test
  • Science
  • About
    • Company
    • Leadership
  • News
  • Careers
Select Page
Protein Measured by a Blood Test Marks Joint Erosions in Arthritis

Protein Measured by a Blood Test Marks Joint Erosions in Arthritis

by Simran Chahal | Jun 15, 2012 | Health, News

At Europe’s premier arthritis congress, the European League Against Rheumatism (EULAR) last week in Berlin, researchers presented findings that a protein measurable in blood named 14-3-3η, marks the presence of joint damage in two different forms of arthritis,...
Novel Blood Test Identifies Patients with Early Rheumatoid Arthritis; Findings Reported at the American College of Rheumatology (ACR)

Novel Blood Test Identifies Patients with Early Rheumatoid Arthritis; Findings Reported at the American College of Rheumatology (ACR)

by Simran Chahal | Nov 18, 2011 | Health, News

Not unlike cancer, disease outcome can be dramatically improved if RA is caught and treated early. Augurex Life Sciences Corp. reported that in Chicago at the American College of Rheumatology (ACR) Annual Scientific Meeting, world-leading arthritis researchers from...
Augurex Reports Positive Data for RA Blood Test and Drug Target at the Annual European Congress of Rheumatology (EULAR)

Augurex Reports Positive Data for RA Blood Test and Drug Target at the Annual European Congress of Rheumatology (EULAR)

by Simran Chahal | May 28, 2011 | Health, News

Company’s novel biomarker and drug target could represent the first personalized medicine in RA promise for future targeted therapy in a multi-factorial disease. Augurex Life Sciences Corp. today reported that in London at the European League Against Rheumatism...
Page 12 of 12« First«…89101112
©2024 Augurex Life Sciences. All Rights Reserved. Website by Vanooms Media Inc.